7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 
      
    		                                          
      revenue
    		      40,000 139,000 82,000 41,000 360,000 73,000 118,000 35,000 14,000 390,000 66,000 339,000 139,000 21,000 68,000 1,000 21,000 9,000 12,000 17,000 5,000 7,000 31,000 4,000 5,000 12,000 8,000 14,000 11,000 14,000 12,000 12,000 6,000 14,000 10,000 91,000 
      yoy
    		      -88.89% 90.41% -30.51% 17.14% 2471.43% -81.28% 78.79% -89.68% -89.93% 1757.14% -2.94% 33800.00% 561.90% 133.33% 466.67% -94.12% 320.00% 28.57% -61.29% 325.00% 0.00% -41.67% 287.50% -71.43% -54.55% -14.29% -33.33% 16.67% 83.33% 0.00% 20.00% -86.81%     
      qoq
    		      -71.22% 69.51% 100.00% -88.61% 393.15% -38.14% 237.14% 150.00% -96.41% 490.91% -80.53% 143.88% 561.90% -69.12% 6700.00% -95.24% 133.33% -25.00% -29.41% 240.00% -28.57% -77.42% 675.00% -20.00% -58.33% 50.00% -42.86% 27.27% -21.43% 16.67% 0.00% 100.00% -57.14% 40.00% -89.01%  
      product revenue
    		31,780,000 26,421,000 16,509,000 7,206,000 5,954,000 990,000                                     
      other revenues
    		281,000 4,000 8,000 346,000 152,000 57,000                                     
      total revenue
    		32,061,000 26,425,000 16,517,000 7,552,000 6,106,000 1,047,000                                     
      operating costs and expenses
    		                                          
      cost of sales
    		177,000 136,000 58,000                                        
      gross profit
    		                                          
      yoy
    		                                          
      qoq
    		                                          
      gross margin %
    		      0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 
      research and development
    		48,661,000 52,430,000 45,976,000 35,221,000 50,443,000 51,129,000 53,351,000 51,532,000 48,402,000 53,168,000 79,264,000 58,077,000 71,612,000 63,082,000 55,378,000 51,753,000 49,277,000 53,800,000 41,128,000 20,256,000 17,284,000 13,709,000 13,234,000 12,004,000 12,052,000 13,131,000 12,598,000 12,480,000 14,559,000 14,688,000 13,991,000 12,021,000 11,069,000 9,706,000 9,248,000 9,445,000 8,364,000 6,389,000 4,944,000 5,106,000 3,950,000 1,745,000 
      research and development – related parties
    		2,571,000 2,806,000 2,258,000                                        
      selling, general and administrative
    		35,508,000 41,862,000 31,977,000 41,731,000 35,916,000 49,251,000 41,885,000 33,110,000 31,816,000 32,018,000 32,676,000 26,215,000 19,310,000 16,575,000 40,608,000 27,911,000 29,625,000 32,445,000 45,275,000 10,651,000 4,711,000 6,519,000 5,373,000 4,116,000 4,025,000 4,182,000 5,742,000 5,246,000 9,580,000 13,594,000 14,298,000 13,385,000 13,381,000 14,128,000 16,227,000 15,713,000 24,423,000 28,588,000 26,651,000 74,831,000 38,854,000 82,429,000 
      selling, general and administrative – related parties
    		774,000 476,000 677,000                                        
      total operating costs and expenses
    		87,691,000 97,710,000 80,946,000 76,952,000 86,359,000 100,380,000                                     
      income from operations
    		-55,630,000 -71,285,000 -64,429,000 -69,400,000 -80,253,000 -99,333,000 -95,196,000 -85,389,000 -80,136,000 -85,145,000 -111,580,000 -84,900,000 -90,804,000 -79,622,000 -95,972,000 -79,274,000 -78,836,000 -85,906,000 -86,264,000 -30,886,000 -21,927,000 -20,227,000 -18,586,000 -16,111,000 -16,065,000 -17,296,000 -18,335,000 -17,719,000 -24,108,000 -28,278,000 -28,284,000 -25,394,000 -24,442,000 -23,820,000 -25,464,000 -25,144,000 -32,775,000 -34,965,000 -31,589,000 -79,923,000 -42,794,000 -84,083,000 
      yoy
    		-30.68% -28.24% -32.32% -18.72% 0.15% 16.66% -14.68% 0.58% -11.75% 6.94% 16.26% 7.10% 15.18% -7.31% 11.25% 156.67% 259.54% 324.71% 364.13% 91.71% 36.49% 16.95% 1.37% -9.08% -33.36% -38.84% -35.18% -30.22% -1.37% 18.72% 11.07% 0.99% -25.42% -31.87% -19.39% -68.54% -23.41% -58.42%     
      qoq
    		-21.96% 10.64% -7.16% -13.52% -19.21% 4.35% 11.49% 6.56% -5.88% -23.69% 31.43% -6.50% 14.04% -17.04% 21.06% 0.56% -8.23% -0.42% 179.30% 40.86% 8.40% 8.83% 15.36% 0.29% -7.12% -5.67% 3.48% -26.50% -14.75% -0.02% 11.38% 3.89% 2.61% -6.46% 1.27% -23.28% -6.26% 10.69% -60.48% 86.76% -49.11%  
      operating margin %
    		      -237990.00% -61430.94% -97726.83% -207670.73% -30994.44% -116301.37% -76952.54% -227491.43% -685514.29% -20326.67% -119448.48% -25341.00% -62060.43% -147076.19% -32245.59% -2022700.00% -88504.76% -179011.11% -133875.00% -101741.18% -366700.00% -253128.57% -77767.74% -706950.00% -565680.00% -211616.67% -305525.00% -170142.86% -231490.91% -179600.00% -273125.00% -291375.00% -526483.33% -570878.57% -427940.00% -92398.90% 
      other income
    		-187,000 -278,000 -41,000 10,000 12,000 -17,000 -20,000 -71,000 -1,047,000 -28,000 -1,077,000 -923,000 6,000 185,000 -4,000 -59,000 -38,000 277,000 13,000 -1,272,000 96,000 67,000 32,000 112,000 56,000 83,000 47,000 -19,000 47,000 39,000 169,000 244,000 87,000 -283,000 109,000 -1,000 60,000 1,000 28,000 -87,000 61,000  
      interest and investment income
    		2,067,000 1,153,000 887,000 1,187,000 1,798,000 1,891,000 3,099,000 484,000 35,000 -61,000 673,000 -3,813,000 857,000 -1,800,000 1,666,000 -6,926,000 -5,941,000 -177,000 8,944,000                        
      interest expense – related party
    		-15,256,000 -15,474,000 -15,313,000                                        
      change in fair value of warrant liabilities
    		14,905,000 3,889,000 -448,000 9,733,000 31,324,000 -19,300,000 -1,802,000 -79,400,000 14,265,000 -10,019,000 27,554,000                                
      interest expense related to revenue interest liability
    		-12,302,000 -13,405,000 -13,534,000 -11,503,000 -10,925,000 -9,225,000 -8,004,000                                    
      change in fair value of related-party convertible note
    		-1,169,000 1,169,000 -42,582,000                                        
      change in fair value of derivative liabilities
    		289,000 1,931,000 5,578,000 -6,607,000 1,614,000 21,194,000 -2,724,000                                    
      interest expense
    		-26,000 -5,000 -18,000 -26,071,000 -29,322,000 -29,794,000 -29,483,000 -32,126,000 -35,021,000 -32,235,000 -29,816,000 -28,562,000 -16,764,000 -9,698,000 -8,491,000 -4,490,000 -3,614,000 -3,577,000 -3,168,000 -22,000 -9,000 -3,000 -7,000 -11,000 -5,000  -3,000 -145,000 -149,000 -106,000 -33,000 -34,000 -393,000 -154,000 -37,000 -37,000 -29,000      
      total other income
    		-11,679,000 -21,020,000 -65,471,000 10,221,000 -5,499,000 -35,251,000 -38,934,000 -148,065,000 -15,506,000 -53,068,000 -5,003,000 -23,392,000 -20,357,000 -15,213,000 -7,026,000 -12,278,000 -9,593,000 -3,477,000 5,789,000 -1,247,000 153,000 139,000 203,000 407,000 484,000 616,000 414,000 251,000 345,000 423,000 641,000 735,000 374,000 244,000 851,000 757,000 826,000 740,000 796,000 -275,250 145,000  
      income before income taxes and noncontrolling interests
    		-67,309,000 -92,305,000 -129,900,000 -59,179,000 -85,752,000 -134,584,000 -134,130,000 -233,454,000 -95,642,000 -138,213,000 -116,583,000 -108,292,000 -111,161,000 -94,835,000 -102,998,000 -91,552,000 -88,429,000 -89,383,000 -80,475,000                        
      income tax benefit
    		35,000  234,000             -1,000    1,000 -2,000 -4,000  63,000  -2,000 36,000 128,000 128,000 123,000 -124,000 -172,000 -99,000 -124,000 -98,000        
      net income
    		-67,274,000 -92,574,000 -129,666,000 -59,179,000 -85,752,000 -134,584,000 -134,130,000 -233,414,000 -95,642,000 -138,213,000 -116,583,000 -108,326,000 -111,161,000 -94,835,000 -102,998,000 -91,553,000 -88,429,000 -89,385,000 -80,481,000 -32,132,000 -21,776,000 -20,092,000 -18,383,000 -15,641,000 -15,581,000 -16,682,000 -17,885,000 -17,340,000 -23,635,000 -27,732,000 -27,519,000 -24,487,000 -23,969,000 -23,452,000 -24,515,000 -24,238,000 -31,897,000 -33,997,000 -30,650,000 -76,821,000 -42,649,000 -84,581,000 
      yoy
    		-21.55% -31.21% -3.33% -74.65% -10.34% -2.63% 15.05% 115.47% -13.96% 45.74% 13.19% 18.32% 25.71% 6.10% 27.98% 184.93% 306.08% 344.88% 337.80% 105.43% 39.76% 20.44% 2.78% -9.80% -34.08% -39.85% -35.01% -29.19% -1.39% 18.25% 12.25% 1.03% -24.86% -31.02% -20.02% -68.45% -25.21% -59.81%     
      qoq
    		-27.33% -28.61% 119.11% -30.99% -36.28% 0.34% -42.54% 144.05% -30.80% 18.55% 7.62% -2.55% 17.22% -7.93% 12.50% 3.53% -1.07% 11.06% 150.47% 47.56% 8.38% 9.30% 17.53% 0.39% -6.60% -6.73% 3.14% -26.63% -14.77% 0.77% 12.38% 2.16% 2.20% -4.34% 1.14% -24.01% -6.18% 10.92% -60.10% 80.12% -49.58%  
      net income margin %
    		      -335325.00% -167923.74% -116636.59% -337104.88% -32384.17% -148391.78% -94204.24% -270957.14% -735700.00% -23475.13% -133983.33% -26367.26% -57900.00% -153009.52% -32023.53% -2009200.00% -87538.10% -173788.89% -129841.67% -98129.41% -357700.00% -247714.29% -76241.94% -693300.00% -550380.00% -204058.33% -299612.50% -167514.29% -222863.64% -173128.57% -265808.33% -283308.33% -510833.33% -548721.43% -426490.00% -92946.15% 
      net income attributable to noncontrolling interests, net of tax
    		-21,000 -19,000 -20,000 -17,000 -23,000 -20,000 -21,000 -22,000 -60,000 -334,000 -240,000 -111,000 -223,000 -247,000 -172,000 -294,000 -800,000 -1,097,000 -867,000                        
      net income attributable to immunitybio common stockholders
    		-67,253,000 -92,555,000 -129,646,000 -59,162,000 -85,729,000 -134,564,000 -134,109,000 -233,392,000 -95,582,000 -137,879,000 -116,343,000 -108,215,000 -110,938,000 -94,588,000 -102,826,000 -91,259,000 -87,629,000 -88,288,000 -79,614,000                        
      net income per immunitybio common share – basic
    		-70 -100 -150 -70 -120          -260                            
      net income per immunitybio common share – diluted
    		-70 -100 -150 -90 -140          -260                            
      weighted-average number of common shares used in computing net income per share – basic
    		946,601 888,216 853,162 697,312 695,895                                      
      weighted-average number of common shares used in computing net income per share – diluted
    		946,601 888,216 853,162 700,443 697,961                                      
      income tax expense
    		 -269,000                -2,000 -6,000                     250   
      cost of product revenue
    		                                          
      loss on equity method investment
    		        -1,255,000 -3,957,000 -2,337,000 -3,554,000 -4,456,000 -3,900,000 -197,000                            
      net income per immunitybio common share – basic and diluted
    		     -200 -200 -380 -190 -320 -270 -270 -280 -240  -165 -220 -230 -210                        
      weighted-average number of common shares used in computing net income per share – basic and diluted
    		     686,938,120 672,831,258 508,635,592 498,375,316 437,456,657 428,381,485 399,900,374 400,059,707 397,991,630 397,882,441 389,234,156 391,853,623 384,820,486 382,741,464                        
      operating expenses:
    		                                          
      total operating expenses
    		      95,236,000 85,528,000 80,218,000 85,186,000 111,940,000 84,973,000 90,922,000 79,657,000 95,986,000 79,664,000 78,902,000 86,245,000 86,403,000 30,907,000 21,995,000 20,228,000 18,607,000 16,120,000 16,077,000 17,313,000 18,340,000 17,726,000 24,139,000 28,282,000 28,289,000 25,406,000 24,450,000 23,834,000 25,475,000 25,158,000 32,787,000 34,977,000 31,595,000 79,937,000 42,804,000 84,174,000 
      other income, net:
    		                                          
      change in fair value of convertible note
    		       187,250 7,517,000 -6,768,000                                 
      impairment of intangible assets
    		                                          
      other income:
    		                                          
      investment income
    		                   47,000 66,000 75,000 178,000 306,000 433,000 533,000 370,000 415,000 447,000 490,000 505,000 525,000 680,000 681,000 779,000 795,000 795,000 739,000 768,000    
      income before income taxes
    		                   -32,133,000 -21,774,000 -20,088,000 -18,383,000 -15,704,000 -15,581,000 -16,680,000 -17,921,000 -17,468,000 -23,763,000 -27,855,000 -27,643,000 -24,659,000 -24,068,000 -23,576,000 -24,613,000 -24,387,000 -31,949,000 -34,225,000 -30,793,000 -77,123,000 -42,649,000 -84,581,000 
      net income per share
    		                                          
      basic and diluted
    		                   -0.3 -0.2 -0.2 -0.19 -0.16 -0.16 -0.17 -0.22 -0.22 -0.3 -0.35 -0.35 -0.31 -0.3 -0.29 -0.3 -0.29 -0.39 -0.41 -0.38 -0.97 -0.55 -1.29 
      weighted-average number of shares during the period:
    		                                          
      basic and diluted
    		                   103,550,936 108,246,579 98,769,687 98,472,641 94,210,087 98,331,695 98,594,355 81,261,302 79,132,220 79,204,765 79,107,208 79,036,614 80,583,910 79,440,591 81,440,816 82,138,438 81,979,005 82,154,219 81,959,248 81,574,709 71,519,609 77,837,586 65,789,041 
      change in fair value of warrant liability
    		                                          
      income tax (benefit) expense
    		                                   -149,000 -52,000 -228,000 -143,000    
      interest income
    		                                       25,250 84,000 -15,000 
      fair value adjustment
    		                                       -341,500  -483,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.